1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. PPAR
  4. PPARγ Inhibitors

PPARγ Inhibitors

PPARα

PPARβ/δ

PPARγ

PPAR

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform PPARγ together.

Please try each isoform separately.

PPARγ Specific Inhibitors, Agonists, Antagonists, Activators & Modulators
Product Name PPARγ PPARα PPARβ/δ PPARγ Selectivity Purity
Rosiglitazone
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
    Selective Agonist 99.54%
Pioglitazone
hPPARγ, EC50: 0.93 μM
mouse PPARγ, EC50: 0.99 μM
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
Selective Activator ≥98.0%
Rosiglitazone hydrochloride
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
    Selective Agonist
T0070907
PPARγ, Ki: 1 nM
PPARα, Ki: 0.85 μM
PPARδ, Ki: 1.8 μM
Selective Antagonist 99.98%
Troglitazone
PPARγ, EC50: 550 nM (Human PPARγ)
    Selective Agonist 99.53%
5-Aminosalicylic Acid
PPARγ
    Selective Agonist ≥98.0%
GW1929
PPAR-γ, pEC50: 8.56 (Human PPAR-γ)
    Selective Agonist 99.77%
Astaxanthin
PPARγ
    Selective Modulator ≥98.0%
Magnolol
PPARγ, EC50: 17.7 μM
    Selective Agonist 99.92%
Rosiglitazone maleate
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
    Selective Agonist 99.75%
Glabridin
PPARγ, EC50: 6.1 μM
    Selective Activator 99.98%
Balaglitazone
PPARγ, EC50: 351 nM (Human PPARγ)
    Selective Agonist 99.97%
Inolitazone dihydrochloride
PPARγ
    Selective Agonist 98.36%
Mifobate
PPARγ, IC50: 140 μM
    Selective Inhibitor ≥99.0%
EHP-101
PPARγ
    Selective Agonist 98.56%
Adelmidrol
PPARγ
    Selective Activator ≥98.0%
Cefminox sodium
PPARγ
    Selective Agonist 99.83%
15-Deoxy-Δ-12,14-prostaglandin J2
PPARγ, EC50: 2 μM
    Selective Agonist ≥96.0%
GSK376501A
PPARγ
    Selective Agonist 99.06%
Methyl oleanonate
PPARγ
    Selective Agonist 99.49%
Caulophyllogenin
PPARγ, EC50: 12.6 μM
    Selective Agonist
Darglitazone
PPAR-γ
    Selective Agonist
Angeloylgomisin H
PPAR-γ
    Selective Activator
DS-6930
PPARγ, EC50: 41 nM
    Selective Agonist
4-O-Methyl honokiol
PPARγ
    Selective Agonist 99.65%
Inolitazone
PPARγ
    Selective Agonist
Arhalofenate
PPAR-γ
    Selective Agonist
Retinoic acid
PPARγ, Kd: 178 nM
PPARα, Kd: 103 nM
PPARβ/δ, Kd: 17 nM
Pan Agonist 99.74%
GW9662
PPARγ, IC50: 3.3 nM
PPARα, IC50: 32 nM
PPARδ, IC50: 2000 nM
Pan Antagonist 99.83%
Saroglitazar
PPARγ, EC50: 3 nM (HepG2 cell)
PPARα, EC50: 0.65 pM (HepG2 cell)
  Pan Agonist 98.03%
Pirinixic acid
PPARγ, EC50: 32 μM
PPARα, EC50: 0.63 μM
  Pan Agonist 98.81%
Daidzein
PPAR-γ
PPAR-α
  Pan Activator ≥98.0%
GW7647
PPARγ, EC50: 1.1 μM (Human PPARγ)
PPARα, EC50: 6 nM (Human PPARα)
PPARδ, EC50: 6.2 μM (Human PPARδ)
Pan Agonist ≥98.0%
CDDO-Im
PPARγ, Ki: 344 nM
PPARα, Ki: 232 nM
  Pan Activator 98.19%
Bezafibrate
hPPARγ, EC50: 60 μM
hPPARα, EC50: 50 μM
hPPARδ, EC50: 20 μM
Pan Agonist ≥98.0%
GW0742
PPARγ, EC50: 2 μM
PPARα, EC50: 1.1 μM
PPARδ, EC50: 1 nM
Pan Agonist 97.27%
Pioglitazone hydrochloride
PPARγ, EC50: 43 μM (Human PPARγ)
PPARα, EC50: 0.93 μM (Human PPARα)
PPARδ, EC50: 0.01 μM (Human PPARδ)
Pan Agonist 99.75%
Lanifibranor
PPARγ, EC50: 206 nM (Human PPARγ)
PPARα, EC50: 1537 nM (Human PPARα)
PPARδ, EC50: 866 nM (Human PPARδ)
Pan Agonist 99.56%
Clofibrate
PPARγ, EC50: 500 μM
PPARα, EC50: 50 μM
  Pan Agonist 99.61%
NXT629
hPPARγ, IC50: 15 μM
hPPARα, IC50: 77 nM
hPPARδ, IC50: 6 μM
Pan Antagonist 99.05%
Fenofibric acid
PPARγ, EC50: 1.47 μM
PPARα, EC50: 22.4 μM
PPARδ, EC50: 1.06 μM
Pan Agonist ≥98.0%
Ginsenoside Rh1
PPAR-γ
    Pan Inhibitor ≥98.0%
Saroglitazar Magnesium
PPARγ, EC50: 3 nM (HepG2 cell)
PPARα, EC50: 0.65 pM (HepG2 cell)
  Pan Agonist 98.85%
Oleuropein
PPARγ
    Pan Inhibitor 98.54%
L-165041
PPARγ, Ki: 730 nM
 
PPARδ, Ki: 6 nM
Pan Agonist 99.74%
Indeglitazar
PPARγ
PPARα
PPARδ
Pan Agonist 99.59%
Alpinetin
PPAR-γ
    Pan Activator 99.07%
Agrimol B
PPARγ
    Pan Inhibitor 99.72%
Aleglitazar
PPARγ, IC50: 19 nM
PPARα, IC50: 38 nM
  Pan Agonist 99.30%
LJ570
PPARγ, EC50: 0.12 μM
PPARα, EC50: 1.05 μM
  Pan Agonist
Chiglitazar
PPARγ, EC50: 0.08 μM
PPARα, EC50: 1.8 μM
PPARδ, EC50: 1.7 μM
Pan Agonist
CP-868388 free base
hPPARγ, Ki: 3.47 μM
hPPARα, Ki: 10.8 nM
  Pan Agonist
Imiglitazar
PPARγ1, EC50: 31 nM
PPARα, EC50: 67 nM
  Pan Agonist
PPAR agonist 1
PPARγ
PPARα
  Pan Agonist
Glabrone
PPAR-γ
   
Licarin B
PPARγ
    Activator